Clinical trial
Use of Insulin Glargine to Treat Diabetic Ketoacidosis
NCT00179127 · Vanderbilt University Medical Center, Other · Completed
Key facts
| NCT number | NCT00179127 |
|---|---|
| Title | Use of Insulin Glargine to Treat Diabetic Ketoacidosis |
| Official title | Early Use of Insulin Glargine in Diabetic Ketoacidosis |
| Lead sponsor | Vanderbilt University Medical Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetic Ketoacidosis |
| Intervention type | Drug |
| Interventions | glargine, saline |
| Enrollment | 75 |
| Start date | Aug 1, 2004 |
| Primary completion | Jul 1, 2009 |
| Completion | Sep 1, 2012 |
| First posted | Sep 15, 2005 |
| Last update posted | Jul 16, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: